pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Jaypirca · news · pharmadog
← back to Jaypirca
News mentioning Jaypirca
20
stories
4d
Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concerns
biospace
4d
Merck axes $2.7B BTK inhibitor program after seeing phase 3 data
fiercebiotech
Oct 13, 26
Nurix drops one BTK degrader as momentum builds behind Roche-partnered option
fiercebiotech
Oct 7, 26
STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few
stat
Oct 7, 26
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
stat
Oct 6, 26
STAT+: AstraZeneca opens new Boston site
stat
Oct 6, 26
STAT+: Are stem cell treatments about to have their day?
stat
Oct 6, 26
Opinion: Why the FDA should not approve an ineffective multicancer screening test
stat
Oct 5, 26
STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit
stat
Oct 5, 26
STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
stat
Oct 5, 26
STAT+: New Trump regulations would clean up health care pricing disclosures
stat
Oct 5, 26
STAT+: Prices, prices, prices
stat
Oct 5, 26
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
stat
Oct 5, 26
Genmab details ovarian cancer data; Lilly's Jaypirca gets a label expansion
endpoints
Oct 5, 26
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
biopharma dive
Oct 5, 26
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
stat
Jun 26, 26
On second try, Acadia drug gets nod from European regulators
biopharma dive
Jun 15, 26
Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyout
endpoints
May 13, 26
CLL-321 Trial Efficacy and Safety Results Analysis
onclive
May 13, 26
BRUIN CLL-321 Trial Impact and Treatment Selection
onclive